Globenewswire
Search documents
LU Investor News: If You Have Suffered Losses in Lufax Holding Ltd (NYSE: LU), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Globenewswire· 2026-02-20 23:49
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lufax Holding Ltd (NYSE: LU) resulting from allegations that Lufax may have issued materially misleading business information to the investing public. So What: If you purchased Lufax securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The ...
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
Globenewswire· 2026-02-20 23:47
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2026. SO WHAT: If you purchased REGENXBIO securities during the Class Period you may be enti ...
KD SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Kyndryl Holdings, Inc. Investors - Contact Kirby McInerney LLP by April 13, 2026
Globenewswire· 2026-02-20 23:00
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE:KD) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Kyndryl investments, you have until April 13, 2026 to request lead plaintiff appointment. Court ...
K2 Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on February 25, 2026
Globenewswire· 2026-02-20 23:00
Core Viewpoint - K2 Capital Acquisition Corp. announced that starting February 25, 2026, holders of its 13,800,000 units from the initial public offering can separately trade Class A ordinary shares and rights included in the units [1] Group 1: Offering Details - The units were offered in an underwritten offering, with D. Boral Capital acting as the sole book-running manager [2] - A registration statement on Form S-1 was declared effective by the SEC on January 28, 2026, and the offering is made only by means of a prospectus [2] Group 2: Trading Information - Units not separated will continue to trade on NASDAQ under the symbol "KTWOU," while separated Class A ordinary shares and rights will trade under the symbols "KTWO" and "KTWOR," respectively [1] - Holders must contact the Company's transfer agent, VStock Transfer, to separate their units into Class A ordinary shares and rights [1] Group 3: Company Overview - K2 Capital Acquisition Corp. is a blank check company, also known as a special purpose acquisition company (SPAC), formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [4]
Berger Montague PC Investigating Claims on Behalf of Investors in NuScale Power Corporation (NYSE: SMR) After Class Action Filing
Globenewswire· 2026-02-20 23:00
PHILADELPHIA, Feb. 20, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against NuScale Power Corporation (NYSE: SMR) (“NuScale” or the “Company”) on behalf of investors who purchased or otherwise acquired NuScale securities during the period from May 13, 2025 through November 6, 2025 (the “Class Period”). Investor Deadline: Investors who purchased NuScale securities during the Class Period may, no later than April 20, 2026, seek ...
Investigation Launched into Cogent Communications Holdings, Inc. (CCOI), Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – RGRD Law
Globenewswire· 2026-02-20 22:44
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Cogent Communications Holdings, Inc. (NASDAQ: CCOI) focused on whether Cogent Communications as well as certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Cogent Communications investigation or if you are a Cogent ...
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Paysafe Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – PSFE
Globenewswire· 2026-02-20 22:32
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Paysafe Limited (NYSE: PSFE) between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline. SO WHAT: If you purchased Paysafe securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: T ...
Helios Fairfax Partners Corporation Closes Amendment to Credit Facility
Globenewswire· 2026-02-20 22:30
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (“Helios Fairfax”) (TSX: HFPC.U) announces that it has closed an amendment and restatement of its existing credit facility with FirstRand Bank Limited (acting through its Rand Merchant Bank division) (the “Amended Credit Facility”). The key modifications to the Amended Credit Facility include the following: Facility Increase: The lenders have in ...
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
Globenewswire· 2026-02-20 22:20
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that Psyence Labs Ltd., a leading developer and manufacturer of pharmaceutical-grade psychedelic compounds ("PsyLabs") has exercised its rights under a previously disclosed put option agreement (the "Put Option Agreement"), pursuant to which Psyence BioMed wi ...
Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results
Globenewswire· 2026-02-20 22:16
Core Viewpoint - Constellation Software Inc. has announced a change in the date and time for its fourth quarter conference call, which will now take place on March 9, 2026, at 8:30 am [1]. Group 1: Conference Call Details - The quarterly results will be released via press release and will be available on the company's website and SEDAR+ at 7:00 am EST on March 9, 2026 [2]. - Key executives, including Mark Miller (President), Jamal Baksh (Chief Financial Officer), and Bernard Anzarouth (Chief Investment Officer), will be present during the conference call to address questions regarding the company's results [2]. - To access the call, participants can dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) using conference ID 8822692 [3]. Group 2: Company Overview - Constellation Software Inc. specializes in acquiring, managing, and building vertical market software businesses [4].